KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Cash from Investing Activities (2016 - 2025)

Arbutus Biopharma (ABUS) has disclosed Cash from Investing Activities for 13 consecutive years, with -$1.4 million as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities fell 110.15% to -$1.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $15.6 million through Dec 2025, down 32.11% year-over-year, with the annual reading at $15.6 million for FY2025, 32.11% down from the prior year.
  • Cash from Investing Activities hit -$1.4 million in Q4 2025 for Arbutus Biopharma, up from -$10.0 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $22.2 million in Q4 2023 to a low of -$60.1 million in Q1 2022.
  • Historically, Cash from Investing Activities has averaged $84050.0 across 5 years, with a median of $10.1 million in 2023.
  • Biggest five-year swings in Cash from Investing Activities: skyrocketed 858.89% in 2021 and later crashed 429.6% in 2022.
  • Year by year, Cash from Investing Activities stood at -$8.1 million in 2021, then soared by 256.16% to $12.7 million in 2022, then skyrocketed by 75.25% to $22.2 million in 2023, then tumbled by 39.66% to $13.4 million in 2024, then tumbled by 110.15% to -$1.4 million in 2025.
  • Business Quant data shows Cash from Investing Activities for ABUS at -$1.4 million in Q4 2025, -$10.0 million in Q3 2025, and $15.6 million in Q2 2025.